Jayanthi Mathaiyan

3PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 17, 2026
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.

Swetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss

|Jun 13, 2025
Adverse Drug Reaction Profile of Capecitabine-based Chemotherapy Regimen and its Predisposing Factors in Patients Attending a Tertiary Care Hospital in South India.

Avishek Amar, Jayanthi Mathaiyan, Biswajit Dubashi

|Jan 14, 2025
Incremental cost of treating antimicrobial-resistant infections among hospitalised patients in India: a cohort study.

Abhijit Kadam, Megha Mamulwar, Gayatri Bhambure

Pageof 1

Frequent Collaborators

1 joint publications

Megha Mamulwar

1 joint publications

Gayatri Bhambure

1 joint publications

Shilpa Bembalkar

1 joint publications

Shraddha Bapat